Phase 2 study of talabostat and cisplatin in stage IV melanoma.

被引：0
|
作者：
Uprichard, MJ
O'Day, SJ
Pavlick, AC
Richards, DA
Frenette, G
Stephenson, J
Anthony, S
Pacciucci, PA
Vrhovac, V
Cunningham, C
机构：
[1] Point Therapeut, Boston, MA USA
[2] Inst Canc Res, Med Grp, Los Angeles, CA USA
[3] NYU, Kaplan Canc Ctr, New York, NY 10016 USA
[4] Tyler Canc Ctr, Tyler, TX USA
[5] Carolinas Med Ctr, Charlotte, NC USA
[6] Canc Ctr Carolinas, Greenville, SC USA
[7] Canc Ctr NW, Spokane, WA USA
[8] Mary Crowley Med Res Ctr, Dallas, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：725S / 725S
页数：1
相关论文
共 50 条
  • [41] Active specific immunotherapy with a polyvalent cancer vaccine prolongs survival in AJCC stage IV melanoma.
    Morton, DL
    Essner, R
    Hsueh, EC
    Wanek, LA
    Foshag, LJ
    O'Day, SJ
    Gupta, RK
    Hoon, DS
    Gammon, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 173S - 173S
  • [42] Effects of ipilimumab on expanded tumor-infiltrating lymphocytes in patients with stage IV malignant melanoma.
    Bloom, Jon
    Donia, Marco
    Andersen, Rikke
    Hadrup, Sine Raker
    Lyngaa, Rikke
    Svane, Inge Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [43] Effect of denileukin diftitox on serum GM-CSF and clinical responses in stage IV melanoma.
    Chesney, J.
    Rasku, M. A.
    Klarer, A. C.
    Miller, D. M.
    Telang, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [44] Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients
    J Atzpodien
    K Terfloth
    M Fluck
    M Reitz
    British Journal of Cancer, 2007, 97 : 1329 - 1332
  • [45] Malignant melanoma. Results of phase-II-RDT-Study
    Schadendorf, D.
    ONKOLOGE, 2007, 13 : 27 - 28
  • [46] Pilot study on interferon alpha-2b toxicity in patients with stage III melanoma.
    Nassif, E
    Sideris, L
    ANNALES DE CHIRURGIE, 1999, 53 (08): : 690 - 692
  • [47] Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients
    Atzpodien, J.
    Terfloth, K.
    Fluck, M.
    Reitz, M.
    BRITISH JOURNAL OF CANCER, 2007, 97 (10) : 1329 - 1332
  • [48] Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
    Steve Boudewijns
    Martine Bloemendal
    Nienke de Haas
    Harm Westdorp
    Kalijn F. Bol
    Gerty Schreibelt
    Erik H. J. G. Aarntzen
    W. Joost Lesterhuis
    Mark A. J. Gorris
    Alexandra Croockewit
    Lieke L. van der Woude
    Michelle M. van Rossum
    Marieke Welzen
    Anna de Goede
    Stanleyson V. Hato
    Winette T. A. van der Graaf
    Cornelis J. A. Punt
    Rutger H. T. Koornstra
    Winald R. Gerritsen
    Carl G. Figdor
    I. Jolanda M. de Vries
    Cancer Immunology, Immunotherapy, 2020, 69 : 477 - 488
  • [49] Stage IV melanoma
    Porensky, Paul
    Chiocca, E. Antonio
    JOURNAL OF NEUROSURGERY, 2012, 117 (02) : 225 - 226
  • [50] Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial
    Boudewijns, Steve
    Bloemendal, Martine
    de Haas, Nienke
    Westdorp, Harm
    Bol, Kalijn F.
    Schreibelt, Gerty
    Aarntzen, Erik H. J. G.
    Lesterhuis, W. Joost
    Gorris, Mark A. J.
    Croockewit, Alexandra
    van der Woude, Lieke L.
    van Rossum, Michelle M.
    Welzen, Marieke
    de Goede, Anna
    Hato, Stanleyson, V
    van der Graaf, Winette T. A.
    Punt, Cornelis J. A.
    Koornstra, Rutger H. T.
    Gerritsen, Winald R.
    Figdor, Carl G.
    de Vries, I. Jolanda M.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (03) : 477 - 488
12345